M&A & Funding

A comprehensive guide to medical device company valuation in 2025-2026 — covering EBITDA and revenue multiples by subsector, valuation methods for pre-revenue and commercial-stage companies, deal structures including earn-outs and CVRs, and the due diligence process.

A practical guide to raising venture capital for medical device startups in 2026 — covering typical raise amounts by stage, what investors evaluate, hot subsectors, the VC ecosystem, and how to position for a successful fundraise.

A comprehensive analysis of the wave of medtech divestitures and spinoffs reshaping the industry — from BD's $17.5B Waters deal to J&J's DePuy Synthes separation, Siemens Healthineers deconsolidation, and Medtronic's MiniMed IPO.

A comprehensive analysis of the medtech and healthcare IPO landscape in 2026 — from Medline's record $6.3B listing and Medtronic's MiniMed Diabetes spinoff IPO to digital health debuts, SPAC resurgence, and what's in the pipeline.

A deep dive into private equity's growing role in medtech — from Blackstone and TPG's landmark $18.3B Hologic take-private to buy-and-build platforms, CDMO acquisitions, the record Medline IPO exit, and PE dry powder deployment strategies.

A comprehensive analysis of the surgical robotics M&A and funding landscape in 2025-2026 — from Intuitive's dominance to the rise of challengers like CMR Surgical, Medtronic Hugo, J&J OTTAVA, and Distalmotion, plus the shift from VC-backed pioneers to PE-led consolidation.

A comprehensive guide to medical device mergers & acquisitions, venture capital funding, and startup investment — covering regulatory due diligence, valuation methods, deal structures, and market trends.